MNI BRIEF: Goolsbee Sees No `Last Mile' Inflation Problem

GOOLSBEE DOESN'T SEE EVIDENCE INFLATION IS STALLING OUT AT 3%

MNI BRIEF: US CRE, Consumer Loan Delinquencies Rising -Fed

MNI BRIEF: Brazil IPCA Inflation Decelerates to 3.69% in April

MNI BRIEF: CNB Concern At Upside Risk, April Minutes Show

MNI China Daily Summary: Friday, May 10

MNI: US APR TREASURY BUDGET 209.5B

MNI: USDA: 2024/2025 CORN PRODUCTION EST 14.86B BSL

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

MNI BRIEF: Poilievre Calls QE 'Scam' And Would Limit BOC Remit

MNI: Growth Drag From Net Zero Carbon Goal Can Be Offset-OECD

© 1982-2023 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Moderna Announce Plan to File FDA, EU Clearance for COVID Vaccine

GLOBAL MARKET/OPINION

US Pharma firm Moderna file new testing results of their COVID vaccine candidate. Highlights of the release include:


  • Vaccine efficacy against COVID-19 was 94.1%; vaccine efficacy against severe COVID-19 was 100%
  • mRNA-1273 continues to be generally well tolerated; no serious safety concerns identified to date
  • FDA has told Company to expect VRBPAC meeting for mRNA-1273 likely on December 17, 2020
  • On when to expect vaccine rollout, Moderna note that they anticipate "shipping of mRNA-1273 to designated distribution points throughout the U.S. will occur shortly after an Emergency Use Authorization is granted."
MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com
Energy BulletsCommodities
MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com
Energy BulletsCommodities

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.